The Wyoming-Incorporated technology company quotes ETH’s potential as a financial organization to prioritize the Ether Leeum priority to the Bitcoin Treasury.
In the Wednesday statement, the BionExus Gene Lab Corporation confirmed the official approval to establish the Etherrium -centered Treasury. This decision has become the first NASDAQ listing company that has set ETH exclusively as a strategic asset.
BionExus adopts the Ether Leeum Treasury.
Wyoming -based technology companies have published Etherrium Strategy White Paper with the announcement on March 5, which briefly explains the theoretical basis for ETH priority over the General Bitcoin Treasury. The company pointed out that Bitcoin offers strong value, but Ethereum creates a wider utility considering the programming financial platform.
BionExus is a key advantage of Bitcoin, welcoming Ether Leeum, considering the ability to generate yields for the holder through steaks. Nevertheless, the technology company admitted that the adoption of institutional investors increased in 2024.
Unlike the BTC, the white paper emphasizes that ETH offers additional imported streams through the seating. In particular, the POS (Steplice-of Steption) mechanism promotes asset holders to get a 3-5%return per year. This income differentiates Etherrium from other manual assets to check the status as an income -generating financial device.
BionExus cited the institutional reliability of Ethereum, with the adoption of major financial institutions, including Fidelity and Blackrock. Institutional absorption verifies the long -term potential and utility of Ether Leeum with financial instruments.
BionExus chief executive Sam Tan has repeated the goal of a technology company that strategically deploys Ethereum over time. Under the approval of the board of directors, the executives announced a bold outlook to pursue the intention of assigning a large portion of the reserves to Etherrium.
Ether Leeum Treasury Preparation
TAN was not a committee compared to the percentage of the company to allocate to the Etherum Treasury. Executives pointed out that the team is ready to prepare for the final shift, but the exact percentage of the Etherum Treasury is not known.
TAN unveiled a continuous discussion on whether BionExus would start operating an validation node or to cooperate with the existing third -party staying provider. He considers the hinge of choice for compliance, efficiency and security, but the company expressed optimism by adjusting Ether Leeum.
BionExus also speaks of an important role in Etherrium in the global financial ecosystem and argues that it supports the value of $ 1 trillion in the annual Starble Recon transaction. In particular, the network presents a payment layer for global largest Stablecoins Tether (USDT) and USD coins (USDC).
BionExus White Paper reference to the PECTRA protocol upgrade that can strengthen the height of Etherrium beyond the Altcoin leader. Upgrades switch to long -term business infrastructure that can trust Etherrium network.
In the future
Despite the optimism depicted by the white paper, the upgrade of PECTRA suffered a number of problems during the SEPOLIA test run. On Wednesday, we will challenge the mirror load blocks witnessed in the Holsky test stage.
BionExus has the first operation in Asia through the Malaysian subsidiary, which performs genome diagnosis along with chemical distribution. Industrial chemicals for the aerospace and automotive sectors calculate 90%of the company’s revenue.
BionExus recently published an RNA -based blood test to detect inflammatory and cancer diseases early. This division accounts for 10%of the company’s total income.
Despite the outlook for Etherum Treasury, the Tan-LED company is fighting financial problems. NASDAQ was notified by a company claiming that it would not comply with the rules to maintain at least $ 1 bid price in December 2024. The parties have reached a temporary exception to restoring regulations by giving a date on May 1. The company plans to reverse the previous shares decision by April 7 this year.
According to a survey on import calls, BionExus has earned $ 9.26 million for 12 months of sales. The market cap is $ 5.88 million. NASDAQ listed companies according to Ticker BGLC increased by 4.37% to 0.3416. According to MarketWatch data, slightly improvement of stock prices is insufficient to reverse a one -year decrease of 59%.
Edit Credit: RCC_BTN / SHUTTERSTOCK.COM